BRILLIANCE trial
Credit: OHSU News
Carlene Knight, who was born with a gene mutation that has caused her to be legally blind, smiles while sitting outside Oregon Health & Science Universitys Casey Eye Institute on April 29, 2021. As a participant in the BRILLIANCE clinical trial, Knight received an experimental gene-editing treatment that aims to improve eye sight. (OHSU/Josh Andersen)